Along with the phase 2b study, F2G and Shionogi are also running a phase 3 trial called OASIS that is comparing olorofim to Astellas’ AmBiome (liposomal amphotericin B) – a standard therapy ...

Renu­ka Singh The com­pa­ny that brought in the taint­ed eye in­jec­tions that left sev­en pa­tients blind­ed in one or both eyes was award­ed over $15 mil­lion in ten­der awards by the Min­istry of ...